Neuropathic Pain After Breast Surgery
CompletedNCT03124511
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
To understand pain pathophysiology in terms of risk factors and protective mechanisms ranging from molecular pathways to societal impacts.
Study details
- Official title
- DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Neuropathic Pain After Breast Surgery
- Conditions
- Chronic Neuropathic Pain, Postoperative
- Chronic Pain, Postoperative
- Chronic Chemotherapy-induced Neuropathic Pain
- Chronic Chemotherapy-induced Pain
- Chronic Chemotherapy-induced Peripheral Neuropathy
- Interventions
- Procedure: Surgery for breast cancer
- Sponsor
- Danish Pain Research Center
- Collaborators
- DOLORisk Consortium; Aarhus University Hospital
- Start date
- 2017-08-15
- Primary completion
- 2021-08-01
- Sex
- Female
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Denmark
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients scheduled for breast cancer resection performed via lumpectomy (partial or segmental mastectomy) or mastectomy with or without sentinel lymph node biopsy and axillary lymph node dissection, and any combinations hereof. * Willingness and ability to comply with study procedures as judged by the site investigator/manager. * Expected availability for follow-up throughout the study, i.e., \~12 months. * Willingness to voluntarily sign and date the study-specific informed consent form. Exclusion Criteria: * Mental incapacity or language barriers precluding adequate understanding of study procedures. * Current alcohol or substance abuse according to the site investigator's medical judgement. * Unsuitability for participation in the study for any other reason, e.g. due to a significant serious underlying condition (e.g. other cancer or AIDS), as determined by the site investigator/manager.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03124511